Colgate-Palmolive (CL) Shares Sold by Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado cut its stake in Colgate-Palmolive (NYSE:CL) by 61.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 373,706 shares of the company’s stock after selling 607,233 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Colgate-Palmolive were worth $27,224,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Pacer Advisors Inc. raised its stake in shares of Colgate-Palmolive by 8.4% during the second quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after buying an additional 1,566 shares during the last quarter. Alliancebernstein L.P. grew its holdings in Colgate-Palmolive by 4.2% during the first quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after purchasing an additional 77,414 shares during the period. Israel Discount Bank of New York acquired a new position in Colgate-Palmolive during the first quarter valued at approximately $1,349,000. Principal Financial Group Inc. grew its holdings in Colgate-Palmolive by 0.6% during the first quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after purchasing an additional 7,905 shares during the period. Finally, Personal Capital Advisors Corp grew its holdings in Colgate-Palmolive by 5.8% during the second quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock valued at $29,209,000 after purchasing an additional 21,456 shares during the period. 72.84% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive (NYSE CL) opened at $75.15 on Friday. The firm has a market cap of $65,559.34, a P/E ratio of 29.02, a PEG ratio of 3.42 and a beta of 0.81. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.73. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.73 earnings per share. sell-side analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.
CL has been the subject of a number of analyst reports. Macquarie initiated coverage on shares of Colgate-Palmolive in a report on Thursday, September 14th. They set a “neutral” rating and a $76.00 price objective for the company. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday, September 20th. Morgan Stanley upgraded shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $75.00 to $84.00 in a report on Monday, September 25th. Jefferies Group restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, September 28th. Finally, Royal Bank of Canada restated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Three equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have issued a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $76.33.
In other news, insider Jennifer Daniels sold 7,375 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the sale, the insider now owns 38,691 shares of the company’s stock, valued at $2,831,407.38. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CMO Mukul Deoras sold 7,500 shares of the business’s stock in a transaction on Friday, November 10th. The stock was sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the sale, the chief marketing officer now directly owns 45,217 shares in the company, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. Insiders sold 181,048 shares of company stock valued at $13,168,995 in the last quarter. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.